Dapsone

氨苯砜

Report date: 2023/12/25 17:32:43
NME

Base Information

Drug NameDapsone
Drug Alias Name氨苯砚dapsone氨二苯枫dapsonum二氨二苯砜 +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)PemphigusLinear IgA Bullous Dermatosis +[18] 
Global Approved IndicationsDermatitis HerpetiformisAcne VulgarisMalaria +[6] 
Approved Indications in ChinaLeprosyInfections
Original Approved Country/TerritoryCanada
Original Approved Date1971/12/31
Country/TerritoryBelizeCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJacobus
China Registration ClassN/A

Develop Information

Active CompaniesAlmirall LlcM/s Dr Reddy`s Laboratories LtdJiangsu Alicom Pharmaceutical Co Ltd +[4] 
Inactive CompaniesJacobus PharmaceuticalTorrent Pharmaceuticals LtdCidat Sa De Cv +[13] 
Active IndicationsDermatitis HerpetiformisAcne VulgarisMalaria +[5] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)PemphigusLinear IgA Bullous Dermatosis +[13] 

Other Information

ATC CodeD10AX05J04BA02
Related LinksWikipediaDrugBankKEGG